Skip to content

Finding the Genes for Gout: the effect of fructose

The influence of genetic variants on fructose-induced hyperuricaemia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12610001036000
Enrollment
76
Registered
2010-11-24
Start date
2011-10-06
Completion date
2012-02-29
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

We have previously identified genetic variation in a urate transporter gene SLC2A9 as a key risk factor for development of gout in those of Maori, Pacific and Caucasian ancestry. This transporter is also a fructose transporter and in vitro assays have shown that fructose promotes transport of urate via SLC2A9. These observations are of clinical relevance, as fructose ingestion has been strongly associated with development of hyperuricaemia and gout. We wish to extend our initial observations by examining the influence of SLC2A9 genetic variation on fructose-induced hyperuricaemia. The primary hypothesis is that individuals possessing at least one protective allele at rs11942223 have a lower hyperuricaemic response to a fructose challenge. This study involves a fructose challenge test for 75 healthy volunteer control participants. The fructose challenge test takes approximately 3 hours and involves ingestion of a fructose/glucose drink and serial measurements of blood urate, creatinine and glucose. Blood will also be obtained for genotyping of SLC2A9 variants and other variants associated with hyperuricaemia

Interventions

A sugar solution of 300kcal/300ml will be administered to all participants. This solution will contain 80% fructose and 20% glucose (64g fructose and 16g glucose). Participants will then be observed for three hours.

Sponsors

Health Research Council of New Zealand
Lead SponsorGovernment body

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

Able to provide written informed consent

Exclusion criteria

a. History of gout b. History of diabetes mellitus c. History of fructose intolerance d. Diuretic use e. Fasting capillary glucose >6mmol/L

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 21, 2026